GI & Endoscopy

Gastroenterologists are still recovering from the COVID-19 pandemic and adapting to new changes in how they practice medicine.

From resources to acquisitions, here are four gastrointestinal pharmaceutical updates:

Colorectal cancer is the third leading cause of cancer-related deaths in the United States, and colorectal cancer screening procedures dropped more than 80 percent in the early stages of the pandemic. 

Exact Sciences completed its acquisition of Ashion Analytics, according to an April 14 announcement.

TriHealth, a Cincinnati-based health system, has sued to enforce a noncompete clause for 18 gastroenterologists who plan to leave the system in June, according to a Cincinnati Business Courier report.

Silver Springs, Md.-based Capital Digestive Care expanded its presence in Virginia, partnering with Suffolk-based Gastrointestinal & Liver Specialists of Tidewater.

Colorectal cancer patients who are younger than 50 have a better survival rate than those diagnosed later, a study from New Haven, Conn.-based Yale University found.

The FDA granted de novo clearance for Medtronic's first artificial intelligence system for colonoscopies.

Here are six recent updates on gastroenterology procedures and devices:

Pristine Surgical and NexOptic have agreed to combine their technologies for a single-use endoscopic visualization platform.